These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4808861)

  • 1. Carcinogenicity of methylchrysenes.
    Hoffmann D; Bondinell WE; Wynder EL
    Science; 1974 Jan; 183(4121):215-6. PubMed ID: 4808861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chrysene and methylchrysenes: presence in tobacco smoke and carcinogenicity.
    Hecht SS; Bondinell WE; Hoffmann D
    J Natl Cancer Inst; 1974 Oct; 53(4):1121-33. PubMed ID: 4427391
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative mutagenicity, tumor-initiating activity, carcinogenicity, and in vitro metabolism of fluorinated 5-methylchrysenes.
    Hecht SS; LaVole E; Mazzarese R; Hirota N; Ohmori T; Hoffmann D
    J Natl Cancer Inst; 1979 Sep; 63(3):855-61. PubMed ID: 288940
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.
    Hecht SS; Amin S; Huie K; Melikian AA; Harvey RG
    Cancer Res; 1987 Oct; 47(20):5310-5. PubMed ID: 3652037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene.
    Hecht SS; Rivenson A; Hoffmann D
    Cancer Res; 1980 May; 40(5):1396-9. PubMed ID: 7370979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumorigenicity of 5-methylchrysene dihydrodiols and dihydrodiol epoxides in newborn mice and on mouse skin.
    Hecht SS; Radok L; Amin S; Huie K; Melikian AA; Hoffmann D; Pataki J; Harvey RG
    Cancer Res; 1985 Apr; 45(4):1449-52. PubMed ID: 3838497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene.
    Amin S; Hecht SS; Di Raddo P; Harvey RG
    Cancer Lett; 1990 May; 51(1):17-20. PubMed ID: 2337893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-initiating activity of fluorinated 5-methylchrysenes.
    Hecht SS; Hirota N; Loy M; Hoffmann D
    Cancer Res; 1978 Jun; 38(6):1694-8. PubMed ID: 647679
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of tobacco carcinogenesis. XI. Tumor initiators, tumor accelerators, and tumor promoting activity of condensate fractions.
    Hoffmann D; Wynder EL
    Cancer; 1971 Apr; 27(4):848-64. PubMed ID: 5574075
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene 1,2-diol-3,4-epoxides on mouse skin and in newborn mice.
    Chang RL; Levin W; Wood AW; Yagi H; Tada M; Vyas KP; Jerina DM; Conney AH
    Cancer Res; 1983 Jan; 43(1):192-6. PubMed ID: 6847768
    [No Abstract]   [Full Text] [Related]  

  • 12. The bay-region geometry of some 5-methylchrysenes: steric effects in 5,6- and 5,12-dimethylchrysenes.
    Zacharias DE; Kashino S; Glusker JP; Harvey RG; Amin S; Hecht SS
    Carcinogenesis; 1984 Nov; 5(11):1421-30. PubMed ID: 6488465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cigarette smoke carcinogenesis: importance of tumor promoters.
    Van Duuren BL; Sivak A; Katz C; Melchionne S
    J Natl Cancer Inst; 1971 Jul; 47(1):235-40. PubMed ID: 5570117
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-, 2-, 3-, 4-, 5- and 6-Methylchrysenes.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1983 Dec; 32():379-97. PubMed ID: 6586673
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative tumor-initiating activity of methylene-bridged and bay-region methylated derivatives of benz[a]anthracene and chrysene.
    Rice JE; Jordan K; Little P; Hussain N
    Carcinogenesis; 1988 Dec; 9(12):2275-8. PubMed ID: 3191573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 6-nitro substitution on 5-methylchrysene tumorigenicity, mutagenicity and metabolism.
    el-Bayoumy K; Amin S; Hecht SS
    Carcinogenesis; 1986 Apr; 7(4):673-6. PubMed ID: 3509952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of tobacco carcinogenesis. X. Tumor promoting activity.
    Wynder EL; Hoffmann D
    Cancer; 1969 Aug; 24(2):289-301. PubMed ID: 5802499
    [No Abstract]   [Full Text] [Related]  

  • 18. High stereoselectivity in mouse skin metabolic activation of methylchrysenes to tumorigenic dihydrodiols.
    Amin S; Huie K; Balanikas G; Hecht SS; Pataki J; Harvey RG
    Cancer Res; 1987 Jul; 47(14):3613-7. PubMed ID: 3594428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen.
    Levin W; Wood AW; Chang RL; Yagi H; Mah HD; Jerina DM; Conney AH
    Cancer Res; 1978 Jun; 38(6):1831-4. PubMed ID: 647691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons.
    Hecht SS; Amin S; Rivenson A; Hoffmann D
    Cancer Lett; 1979 Nov; 8(1):65-70. PubMed ID: 509421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.